Sinovac covid-19 vaccine

Sinovac covid-19 vaccine aka CoronaVac, is an inactivated virus covid-19 vaccine developed by the Chinese company Sinovac Biotech.

News

 * 01 Jun 2021, Politico.eu, WHO lists China’s Sinovac vaccine for emergency use, The jab showed an efficacy of 51 percent against symptomatic disease and 100 percent efficacy in preventing severe covid-19.
 * 04 May 2021, Politico.eu, EU regulator starts review of China’s Sinovac vaccine, The EMA didn’t provide a time frame for its final decision, but it said the process should ‘take less time than normal.’
 * 17 Apr 2021, TheEconomist.com, China presses Hong Kongers to accept a Chinese vaccine, Many would prefer a better one, or distrust the whole process. Most public-health experts have concerns about the way China’s jab has been promoted in Hong Kong but are scared to speak publicly about it, say three such individuals. They worry that discussing the efficacy of a Chinese vaccine will hurt their careers, or even be deemed a violation of the city’s new security law, which bans any act that seriously “undermines” the work of the local or central governments.
 * 15 Apr 2021, TheEconomist.com, In clinical and real world trials, China’s Sinovac underperforms, The vaccine has already been exported to 19 countries. Despite the apparently poor results in stopping infections, the Sinovac vaccine, like its competitors, appears to offer remarkably good protection against severe disease and death. In the Brazil phase-three trials, nearly 4% of the unvaccinated participants who were infected got severely ill; among the vaccinated, none did.
 * 31 Mar 2021, (fr) 7sur7.be, Les vaccins chinois “sûrs et efficaces”, pour l'OMS, Les vaccins des laboratoires chinois Sinopharm et Sinovac ont montré qu’ils étaient sûrs et efficaces contre la Covid-19, mais des données supplémentaires sont nécessaires, ont indiqué mercredi les experts de l’OMS.